Fresenius Medical Care: FDA 510(k) clearances across all its applicant names
FDA lists 202 510(k) clearances, 0 PMA and 0 De Novo decisions across the 10 applicant names Caduvo groups under Fresenius Medical Care, first 1984, latest 2026. Median 510(k) review time across these names: 118 days. Since 2017 the median was 178 days, against 179 days for all cleared 510(k)s in the same product codes. Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 6 | 124 |
| 2013 | 10 | 163 |
| 2014 | 11 | 104 |
| 2015 | 6 | 111 |
| 2016 | 2 | 88 |
| 2017 | 6 | 124 |
| 2018 | 7 | 90 |
| 2019 | 3 | 178 |
| 2020 | 8 | 267 |
| 2021 | 0 | — |
| 2022 | 6 | 257 |
| 2023 | 5 | 230 |
| 2024 | 7 | 184 |
| 2025 | 12 | 116 |
| 2026 | 5 | 189 |
The 10 FDA applicant names in this group
| Applicant name | 510(k) clearances | PMA | De Novo | Years |
|---|---|---|---|---|
| Fresenius Medical Care Renal Therapies Group, LLC | 53 | 0 | 0 | 2013–2026 |
| Nxstage Medical, Inc. | 51 | 0 | 0 | 2001–2024 |
| Fresenius Medical Care North America | 43 | 0 | 0 | 1998–2025 |
| Fresenius USA, Inc. | 38 | 0 | 0 | 1984–1999 |
| Fresenius Medical Care | 7 | 0 | 0 | 2000–2024 |
| Fresenius Medical Care North America, Design Cente | 5 | 0 | 0 | 2010–2013 |
| Fresenius Medical Care South Asia Pacific Pty , Ltd. | 2 | 0 | 0 | 2009–2011 |
| Fresenius Medical Care, North America - Renal Ther | 1 | 0 | 0 | 2014–2014 |
| Fresenius Medical Care Reanal Therapies Group, LLC | 1 | 0 | 0 | 2020–2020 |
| Fresenius Medical Care Rental Therapies Group, LLC | 1 | 0 | 0 | 2022–2022 |
Review time against the same product codes
Since 2017, 510(k)s cleared under these names took a median 178 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 179 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| KDI | Dialyzer, High Permeability With Or Without Sealed Dialysate System | 76 | 76 |
| KPO | Dialysate Concentrate For Hemodialysis (Liquid Or Powder) | 24 | 24 |
| KDJ | Set, Administration, For Peritoneal Dialysis, Disposable | 10 | 10 |
| KOC | Accessories, Blood Circuit, Hemodialysis | 10 | 10 |
| FKP | System, Dialysate Delivery, Single Patient | 9 | 9 |
| FKX | System, Peritoneal, Automatic Delivery | 9 | 9 |
| FIP | Subsystem, Water Purification | 8 | 8 |
| FJK | Set, Tubing, Blood, With And Without Anti-Regurgitation Valve | 8 | 8 |
| FKR | Subsystem, Proportioning | 5 | 5 |
| LKN | Separator, Automated, Blood Cell And Plasma, Therapeutic | 4 | 4 |
Plus 26 more product codes.
Review panels
- Gastroenterology and Urology (184)
- Cardiovascular (6)
- Clinical Chemistry (4)
- Dental (2)
- General Hospital (2)
- Physical Medicine (2)
Most recent Fresenius Medical Care 510(k) clearances
192 earlier clearances. See the full list in Caduvo.
Recalls
82 product recalls in 44 recall events under these names; 11 initiated in the last five years.
142 product recalls in 57 recall events filed under other recalling-firm names cite a 510(k) or PMA held under these applicant names; 49 initiated in the last five years. Most often: Fresenius Medical Care Holdings, Inc. (126), B Braun Medical Inc (13), B BRAUN MEDICAL INC (1).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to the applicant names above by name only, so recalls filed under other names are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
ClinicalTrials.gov lists 4 device studies (0 active or recruiting) with an industry lead sponsor under the 1 sponsor name below. Most recent:
- NCT04511338: Feasibility Study for Heparin-free Hemodialysis With the Dialyzer With Endexo™ (Fresenius Medical Care North America; Completed, started 2020-11-02)
- NCT04573595: Fresenius Noninvasive Blood Pressure Validation (Fresenius Medical Care North America; Completed, started 2020-09-17)
- NCT03536663: Clinical Study to Assess the Performance of the Dialyzer With Endexo™ (Fresenius Medical Care North America; Completed, started 2018-08-29)
- NCT02334267: Acid-Base Composition With Use of hemoDialysates (Fresenius Medical Care North America; Completed, started 2014-11)
| Lead sponsor name on ClinicalTrials.gov | Device studies |
|---|---|
| Fresenius Medical Care North America | 4 |
Sponsor names are matched to the applicant names above by name, with punctuation and legal suffixes removed, plus sponsor names reviewed for this group. Studies listed under other sponsor names are not counted.
Parent company SEC filings
Fresenius Medical Care AG (FMCQF, FMS): EDGAR filings, CIK 1333141. The parent's SEC registrant is entered by hand for this group, not matched by name.
How this group is built
Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.
Fresenius Medical Care and its US arm Fresenius USA, plus NxStage (2019). Includes filings made before the acquisition. Left out: Fresenius Kabi (a separate Fresenius SE business).
Sources
Frequently asked questions
How many FDA 510(k) clearances are listed across Fresenius Medical Care's applicant names?
FDA lists 202 510(k) clearances, 0 PMA and 0 De Novo decisions across the 10 applicant names Caduvo groups under Fresenius Medical Care, first 1984, latest 2026. FDA records each applicant name separately; Caduvo adds up the names listed on this page.
Which FDA applicant names does Fresenius Medical Care file under?
The names with the most 510(k) clearances in this group are Fresenius Medical Care Renal Therapies Group, LLC (53); Nxstage Medical, Inc. (51); Fresenius Medical Care North America (43); Fresenius USA, Inc. (38); Fresenius Medical Care (7). The full list of 10 names is on this page.
How long does FDA take to clear Fresenius Medical Care 510(k)s?
The median time from FDA receipt to decision across 510(k)s cleared under these names is 118 days. Since 2017 the median was 178 days, against 179 days for all cleared 510(k)s in the same product codes.
Does the Fresenius Medical Care count include acquired companies?
Yes. A group includes filings an acquired business made under its own name, including before the acquisition. Businesses that were sold are left out, and names whose ownership is unclear are not included. FDA does not group applicants; the sources for each grouping are listed on this page.
How many device clinical trials does Fresenius Medical Care sponsor?
ClinicalTrials.gov lists 4 device studies (0 active or recruiting) with an industry lead sponsor under 1 sponsor name Caduvo groups under Fresenius Medical Care. ClinicalTrials.gov names the sponsor on each study; Caduvo adds up the names listed on this page.
Next steps
- See all 202 Fresenius Medical Care clearances with predicates and recalls
- Run predicate analysis for product code KDI, Fresenius Medical Care's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this grouping or data. Data and corrections policy.
All parent companies · FDA device companies by applicant name · FDA product code lookup